Salvia divinorum

Salvia, salvinorins & derivatives



Jump to:



Page 4

Serra et al. (2015). Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat. Psychopharmacology.

Simonson et al. (2015). Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A. British Journal of Pharmacology.

Addy et al. (2015). The subjective experience of acute, experimentally-induced Salvia divinorum inebriation. Journal of Psychopharmacology.

Butelman & Kreek (2015). Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders. Frontiers in Pharmacology.

Butelman & Kreek (2015). Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders. Frontiers in Pharmacology.

El-Khoury & Sahakian (2015). The association of Salvia divinorum and psychotic disorders: a review of the literature and case series. Journal of Psychoactive Drugs.

Hernández-Bello et al. (2015). Salvinorin A content in legal high products of Salvia divinorum sold in Mexico.

Maqueda et al. (2015). Salvinorin-A induces intense dissociative effects, blocking external sensory perception and modulating interoception and sense of body ownership in humans. The International Journal of Neuropsychopharmacology.

Crowley et al. (2016). Synthetic studies of neoclerodane diterpenes from salvia divinorum: identification of a potent and centrally acting μ opioid analgesic with reduced abuse liability. Journal of Medicinal Chemistry.

González-Trujano et al. (2016). Depressant effects of salvia divinorum involve disruption of physiological sleep. Phytotherapy Research.

Hutton, Kivell & Boyle (2016). "Quite a Profoundly Strange Experience": An Analysis of the Experiences of Salvia divinorum Users. Journal of Psychoactive Drugs.

Johnson et al. (2016). Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans. Journal of Psychopharmacology.

Li, Morris-Natschke & Lee (2016). Clerodane diterpenes: sources, structures, and biological activities. Natural Products Reports.

Mahendran et al. (2016). Salvia divinorum: An overview of the usage, misuse, and addiction processes. Asia-Pacific Psychiatry.

Maqueda et al. (2016). Naltrexone but not ketanserin antagonizes the subjective, cardiovascular, and neuroendocrine effects of salvinorin-a in humans. The International Journal of Neuropsychopharmacology.

Margalho et al. (2016). Salvia divinorum: toxicological aspects and analysis in human biological specimens. Bioanalysis.

Martinho, Silva & Gallardo (2016). Cytotoxic effects of salvinorin a, a major constituent of salvia divinorum. Medical Chemistry.

Rossi et al. (2016). The hallucinogenic diterpene salvinorin A inhibits leukotriene synthesis in experimental models of inflammation. Pharmacological Research.

Xu et al. (2016). Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study. Journal of Molecular Graphics & Modelling.

Chen et al. (2017). A (-)-kolavenyl diphosphate synthase catalyzes the first step of salvinorin A biosynthesis in Salvia divinorum. Journal of Experimental Botany.

Cruz et al. (2017). A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics. Phytochemistry.

Hatipoglu et al. (2017). Screening of hallucinogenic compounds and genomic characterisation of 40 anatolian salvia species. Phytochemical Analysis.

Paudel et al. (2017). An immunochromatographic assay for rapid etection of salvinorin A. Journal of Immunoassay & immunochemistry.

Pelot et al. (2017). Biosynthesis of the psychotropic plant diterpene salvinorin A: Discovery and characterization of the Salvia divinorum clerodienyl diphosphate synthase. The Plant Journal.

Rossi et al. (2017). Salvinorin A inhibits airway hyperreactivity induced by ovalbumin sensitization. Frontiers in Pharmacology.

Simón-Arceo (2017). Neuropathic and inflammatory antinociceptive effects and electrocortical changes produced by Salvia divinorum in rats. Journal of Ethnopharmacology.

Coffeen et al. (2018). Salvinorin A reduces neuropathic nociception in the insular cortex of the rat. European Journal of Pain.

El-Khoury & Baroud (2018). Case series: Salvia divinorum as a potential addictive hallucinogen. The American Journal of Addiction.